Variant report

Variant	esv3422787
Chromosome Location	chr7:150745069-150747867
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:46)
CpG islands
(count:672)
Chromatin interactive
region (count:2)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:46 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BCL3	chr7:150745029-150745524	A549	lung:	n/a	n/a
2	CEBPB	chr7:150746364-150746518	HepG2	liver:	n/a	n/a
3	E2F6	chr7:150747835-150748619	H1-hESC	embryonic stem cell:	n/a	chr7:150748216-150748225
4	HMGN3	chr7:150746000-150746126	K562	blood:	n/a	n/a
5	MXI1	chr7:150747336-150748663	IMR90	lung:	n/a	n/a
6	NFIC	chr7:150744962-150745505	ECC-1	luminal epithelium:	n/a	chr7:150745251-150745268 chr7:150745251-150745267
7	POLR2A	chr7:150745037-150745413	SK-N-SH	brain:	n/a	n/a
8	POLR2A	chr7:150745519-150745842	A549	lung:	n/a	n/a
9	POLR2A	chr7:150744901-150745810	MCF10A-Er-Src	breast:	n/a	n/a
10	POLR2A	chr7:150747229-150747865	Hela-S3	cervix:	n/a	n/a
11	POLR2A	chr7:150747486-150747730	HepG2	liver:	n/a	n/a
12	POLR2A	chr7:150746207-150746442	A549	lung:	n/a	n/a
13	POLR2A	chr7:150742819-150746720	K562	blood:	n/a	n/a
14	POLR2A	chr7:150746040-150746235	MCF10A-Er-Src	breast:	n/a	n/a
15	POLR2A	chr7:150742860-150745890	SK-N-MC	brain:	n/a	n/a
16	POLR2A	chr7:150743166-150745376	PBDE	blood:	n/a	n/a
17	POLR2A	chr7:150744823-150745168	Hela-S3	cervix:	n/a	n/a
18	POLR2A	chr7:150746230-150746413	A549	lung:	n/a	n/a
19	POLR2A	chr7:150744970-150745212	HUVEC	blood vessel:	n/a	n/a
20	POLR2A	chr7:150747076-150747719	H1-neurons	neurons:	n/a	n/a
21	POLR2A	chr7:150745665-150745711	HUVEC	blood vessel:	n/a	n/a
22	POLR2A	chr7:150742898-150745711	K562	blood:	n/a	n/a
23	POLR2A	chr7:150745246-150745307	IMR90	lung:	n/a	n/a
24	POLR2A	chr7:150745577-150745917	H1-neurons	neurons:	n/a	n/a
25	POLR2A	chr7:150744931-150745796	U87	brain:	n/a	n/a
26	POLR2A	chr7:150746050-150746734	MCF10A-Er-Src	breast:	n/a	n/a
27	POLR2A	chr7:150746215-150746283	K562	blood:	n/a	n/a
28	POLR2A	chr7:150745967-150746474	H1-neurons	neurons:	n/a	n/a
29	POLR2A	chr7:150746504-150746530	MCF10A-Er-Src	breast:	n/a	n/a
30	POLR2A	chr7:150747059-150747586	MCF10A-Er-Src	breast:	n/a	n/a
31	POLR2A	chr7:150745212-150745413	Hela-S3	cervix:	n/a	n/a
32	POLR2A	chr7:150747860-150747866	K562	blood:	n/a	n/a
33	POLR2A	chr7:150742963-150746735	Hela-S3	cervix:	n/a	n/a
34	POLR2A	chr7:150745616-150745691	A549	lung:	n/a	n/a
35	POLR2A	chr7:150747144-150747395	Hela-S3	cervix:	n/a	n/a
36	POLR2A	chr7:150743154-150745571	SK-N-SH	brain:	n/a	n/a
37	POLR2A	chr7:150745610-150745820	A549	lung:	n/a	n/a
38	POLR2A	chr7:150747209-150747674	A549	lung:	n/a	n/a
39	POLR2A	chr7:150744931-150746120	U87	brain:	n/a	n/a
40	POLR2A	chr7:150744183-150745842	A549	lung:	n/a	n/a
41	POLR2A	chr7:150745915-150746237	A549	lung:	n/a	n/a
42	POLR2A	chr7:150743582-150745819	MCF10A-Er-Src	breast:	n/a	n/a
43	POLR2A	chr7:150746722-150748209	K562	blood:	n/a	n/a
44	REST	chr7:150746011-150746339	PANC-1	pancreas:	n/a	n/a
45	REST	chr7:150747750-150748815	HL-60	blood:	n/a	chr7:150748079-150748089
46	REST	chr7:150747822-150748648	ECC-1	luminal epithelium:	n/a	chr7:150748079-150748089

(count:672 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:150745657-150745707	SKMC	muscle:	n/a
2	chr7:150745657-150745707	SKMC	muscle:	n/a
3	chr7:150745709-150745759	ProgFib	skin:	n/a
4	chr7:150745278-150745328	PANC-1	pancreas:	n/a
5	chr7:150745473-150745523	LNCaP	prostate:	n/a
6	chr7:150745278-150745328	MCF10A-Er-Src	breast:	n/a
7	chr7:150746006-150746056	PFSK-1	brain:	n/a
8	chr7:150745657-150745707	ovcar-3	ovarian:	n/a
9	chr7:150745657-150745707	HIPEpiC	eye:	n/a
10	chr7:150746006-150746056	AG09319	gingival:	n/a
11	chr7:150745657-150745707	HL-60	blood:	n/a
12	chr7:150746006-150746056	GM12878	blood:	n/a
13	chr7:150745709-150745759	SK-N-MC	brain:	n/a
14	chr7:150746006-150746056	AG04449	skin:	fetal
15	chr7:150746280-150746330	SKMC	muscle:	n/a
16	chr7:150745278-150745328	GM06990	blood:	n/a
17	chr7:150745473-150745523	AoSMC	blood vessel:	n/a
18	chr7:150746006-150746056	BE2_C	brain:	n/a
19	chr7:150746280-150746330	ECC-1	luminal epithelium:	n/a
20	chr7:150745278-150745328	NHBE	bronchial:	n/a
21	chr7:150745494-150745544	AG04449	skin:	fetal
22	chr7:150746006-150746056	HRPEpiC	eye:	n/a
23	chr7:150747107-150747157	SK-N-SH	brain:	n/a
24	chr7:150745657-150745707	LNCaP	prostate:	n/a
25	chr7:150745657-150745707	SK-N-SH_RA	brain:	n/a
26	chr7:150745680-150745730	HUVEC	blood vessel:	n/a
27	chr7:150746232-150746282	HPAEpiC	pulmonary alveolar:	n/a
28	chr7:150745278-150745328	H1-hESC	embryonic stem cell:	embryo
29	chr7:150746232-150746282	HRCEpiC	kidney:	n/a
30	chr7:150746006-150746056	HMEC	breast:	n/a
31	chr7:150745278-150745328	AoSMC	blood vessel:	n/a
32	chr7:150747107-150747157	ProgFib	skin:	n/a
33	chr7:150745494-150745544	HPAEpiC	pulmonary alveolar:	n/a
34	chr7:150747107-150747157	HCT-116	colon:	n/a
35	chr7:150745487-150745537	HAEpiC	amniotic membrane:	n/a
36	chr7:150746280-150746330	IMR90	lung:	fetal
37	chr7:150745657-150745707	HUVEC	blood vessel:	n/a
38	chr7:150745494-150745544	ProgFib	skin:	n/a
39	chr7:150747107-150747157	HNPCEpiC	eye:	n/a
40	chr7:150746006-150746056	GM19239	blood:	n/a
41	chr7:150746006-150746056	K562	blood:	n/a
42	chr7:150745494-150745544	T-47D	breast:	n/a
43	chr7:150747107-150747157	HEK293	kidney:	embryo
44	chr7:150745494-150745544	NH-A	brain:	n/a
45	chr7:150747107-150747157	SAEC	small airway:	n/a
46	chr7:150745278-150745328	SK-N-SH	brain:	n/a
47	chr7:150745680-150745730	AG04449	skin:	fetal
48	chr7:150745487-150745537	PrEC	prostate:	n/a
49	chr7:150747107-150747157	MCF-7	breast:	n/a
50	chr7:150745278-150745328	AG09319	gingival:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr7:150064606..150067565-chr7:150746513..150748694,2	MCF-7	breast:
2	chr7:150743382..150745288-chr7:151545061..151547871,2	MCF-7	breast:

No data

Variant related genes	Relation type
ASIC3	TF binding region
ASIC3	CpG island
ENSG00000196456	chromatin interactions
ENSG00000214022	chromatin interactions

Extended variants
information (count: 193 )
Associated
traits (count: 87 )

Variant overlapped rSNPs/rCNVs (count:193 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs575418007	chr7:150745140-150745141	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs529466792	chr7:150745155-150745156	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs6947479	chr7:150745173-150745174	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs549345303	chr7:150745176-150745177	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs565997750	chr7:150745217-150745218	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs190796012	chr7:150745229-150745230	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs115008460	chr7:150745237-150745238	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs543504559	chr7:150745248-150745249	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs181914005	chr7:150745264-150745265	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs367552321	chr7:150745279-150745280	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
11	rs537091104	chr7:150745358-150745359	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs557425906	chr7:150745368-150745369	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs567683238	chr7:150745371-150745372	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs536433508	chr7:150745382-150745383	Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs35208708	chr7:150745401-150745402	Weak transcription Genic enhancers Enhancers Bivalent/Poised TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs372471991	chr7:150745409-150745410	Weak transcription Genic enhancers Enhancers Bivalent/Poised TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs148067461	chr7:150745474-150745475	Weak transcription Genic enhancers Enhancers Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
18	rs573148921	chr7:150745495-150745496	Weak transcription Genic enhancers Enhancers Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
19	rs141778240	chr7:150745579-150745580	Weak transcription Genic enhancers Enhancers Bivalent/Poised TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs374818749	chr7:150745589-150745590	Weak transcription Genic enhancers Enhancers Bivalent/Poised TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs558929874	chr7:150745598-150745599	Weak transcription Genic enhancers Enhancers Bivalent/Poised TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs562001247	chr7:150745615-150745616	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs557855606	chr7:150745623-150745624	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs575307125	chr7:150745628-150745629	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs371766506	chr7:150745630-150745631	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs543890889	chr7:150745644-150745645	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs561020971	chr7:150745663-150745664	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
28	rs574461777	chr7:150745681-150745682	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
29	rs559523045	chr7:150745687-150745688	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
30	rs528719557	chr7:150745689-150745690	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
31	rs551649355	chr7:150745710-150745711	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
32	rs138115329	chr7:150745790-150745791	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs190713987	chr7:150745824-150745825	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs572395832	chr7:150745826-150745827	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs558495765	chr7:150745860-150745861	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs550734437	chr7:150745872-150745873	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs567716483	chr7:150745897-150745898	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs536371738	chr7:150745903-150745904	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs565387190	chr7:150745910-150745911	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs566660382	chr7:150745918-150745919	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs202075625	chr7:150745925-150745926	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs200977005	chr7:150745926-150745927	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs368178438	chr7:150745927-150745928	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs372397326	chr7:150745936-150745937	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs377194887	chr7:150745942-150745943	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs373975342	chr7:150745951-150745952	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs150091812	chr7:150745956-150745957	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs143427620	chr7:150745974-150745975	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs200391606	chr7:150745997-150745998	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs554289599	chr7:150746003-150746004	Weak transcription Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:87)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Melanoma	18172304	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	17387387	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Oligodendroglial tumors	17285580	CNVD
Endometrial cancer	22040021	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	21264507	CNVD
Shwachman-Diamond syndrome	22934832	CNVD
Colorectal cancer	19359472	CNVD
Cutaneous malignant melanoma	17690212	CNVD
Leukemia	17361228	CNVD
Breast cancer	16461572	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Malignant melanoma	17690212	CNVD
Renal cell carcinoma	18592004	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Multiple myeloma	17550852	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neurodevelopmental disorder	22521361	CNVD
abortions and stillbirths	19751515	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Burkitt''s lymphoma	19759907	CNVD
lymphocytic leukemia	21291569	CNVD
Acute myeloid leukemia	21251322	CNVD
Prostate cancer	16573809	CNVD
Medulloblastoma	16783165	CNVD
abnormal development	18461090	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Papillary thyroid carcinoma	21436994	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Hodgkin''s lymphoma	18179710	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Breast cancer	17603634	CNVD
Urothelial carcinoma	18382360	CNVD
Myelodysplastic syndrome	17634407	CNVD
Multiple myeloma	16461302	CNVD
Neuroblastoma	18923191	CNVD
Schizophrenia	17646849	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute myeloid leukemia	16864856	CNVD
Autism	20808228	CNVD
Breast cancer	21509527	CNVD
Ovarian cancer	21720365	CNVD
Heart disease	21282601	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	21045282	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Glioblastoma multiforme	17002787	CNVD
Lobular carcinoma	20920651	CNVD
Long-qt syndrome	20920651	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Liver carcinoma	19366792	CNVD
Long-qt syndrome	17576883	CNVD
Bradycardia syndrome	17576883	CNVD
Sudden cardiac death	19188705	CNVD
renal disease	17924346	CNVD
Ovarian cancer	21781307	CNVD
Adrenocortical carcinoma	18281524	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Pancreatic cancer	17952125	CNVD
early-passage human iPS cells	21368824	CNVD

Chromatin state (count:139 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:150726600-150745400	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
2	chr7:150727000-150746400	Weak transcription	Fetal Brain Male	brain
3	chr7:150732400-150745800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
4	chr7:150734000-150748000	Weak transcription	Primary B cells from peripheral blood	blood
5	chr7:150734400-150745200	Weak transcription	iPS-15b Cell Line	embryonic stem cell
6	chr7:150734600-150745400	Weak transcription	Primary neutrophils fromperipheralblood	blood
7	chr7:150734600-150747400	Weak transcription	H9 Cell Line	embryonic stem cell
8	chr7:150734600-150747800	Weak transcription	Primary T helper naive cells from peripheral blood	blood
9	chr7:150736400-150748000	Weak transcription	Psoas Muscle	Psoas
10	chr7:150736800-150745800	Weak transcription	Primary monocytes fromperipheralblood	blood
11	chr7:150736800-150753800	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
12	chr7:150737200-150745200	Weak transcription	Monocytes-CD14+_RO01746	blood
13	chr7:150737800-150748200	Weak transcription	Primary hematopoietic stem cells	blood
14	chr7:150738600-150749600	Weak transcription	K562	blood
15	chr7:150739600-150750000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
16	chr7:150740000-150746600	Weak transcription	Primary T cells fromperipheralblood	blood
17	chr7:150740200-150753800	Weak transcription	Rectal Mucosa Donor 29	rectum
18	chr7:150741400-150748000	Weak transcription	Left Ventricle	heart
19	chr7:150741400-150749400	Weak transcription	Brain Substantia Nigra	brain
20	chr7:150741600-150751200	Weak transcription	Primary B cells from cord blood	blood
21	chr7:150742400-150745200	Enhancers	HSMMtube	muscle
22	chr7:150742600-150748000	Weak transcription	Primary T helper cells PMA-I stimulated	--
23	chr7:150742600-150754400	Weak transcription	Aorta	Aorta
24	chr7:150742800-150745600	Weak transcription	Sigmoid Colon	Sigmoid Colon
25	chr7:150742800-150750200	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
26	chr7:150743000-150745200	Enhancers	HSMM	muscle
27	chr7:150743000-150748000	Weak transcription	Primary T helper cells fromperipheralblood	blood
28	chr7:150743200-150746800	Weak transcription	Fetal Thymus	thymus
29	chr7:150743200-150747800	Weak transcription	Dnd41	blood
30	chr7:150743200-150748000	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
31	chr7:150743200-150748800	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
32	chr7:150743400-150745200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
33	chr7:150743400-150745200	Enhancers	Cortex derived primary cultured neurospheres	brain
34	chr7:150743400-150745800	Enhancers	Fetal Muscle Leg	muscle
35	chr7:150743400-150746200	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
36	chr7:150743400-150748000	Weak transcription	Esophagus	oesophagus
37	chr7:150743400-150748000	Weak transcription	Gastric	stomach
38	chr7:150743600-150745200	Enhancers	NHDF-Ad	bronchial
39	chr7:150743800-150745400	Enhancers	Placenta	Placenta
40	chr7:150743800-150745400	Weak transcription	Thymus	Thymus
41	chr7:150743800-150745600	Weak transcription	Skeletal Muscle Male	skeletal muscle
42	chr7:150743800-150745800	Weak transcription	HUES6 Cell Line	embryonic stem cell
43	chr7:150743800-150746000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
44	chr7:150743800-150747200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
45	chr7:150743800-150747800	Weak transcription	Lung	lung
46	chr7:150743800-150748000	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
47	chr7:150743800-150748000	Weak transcription	Pancreas	Pancrea
48	chr7:150743800-150748000	Weak transcription	Right Ventricle	heart
49	chr7:150743800-150749200	Weak transcription	Brain Inferior Temporal Lobe	brain
50	chr7:150743800-150753800	Weak transcription	Liver	Liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links